Literature DB >> 21620811

Decreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivity.

Monika Karczewska-Kupczewska1, Marek Strączkowski, Agnieszka Adamska, Agnieszka Nikołajuk, Elżbieta Otziomek, Maria Górska, Irina Kowalska.   

Abstract

OBJECTIVE: Insulin resistance and type 2 diabetes are associated with an increased risk of neurodegenerative diseases. Decreased brain-derived neurotrophic factor (BDNF) levels might play a role in the pathogenesis of neuropsychiatric disorders. The aim of our study was to estimate serum BDNF concentration in nonobese women divided into subgroups according to their insulin sensitivity. DESIGN AND METHODS: We studied 46 young, healthy, nonobese women. Insulin sensitivity was estimated with the euglycemic-hyperinsulinemic clamp technique. Then, participants were divided into subgroups of high (mean, 12.79±2.01mg/kg fat-free mass/min) and low insulin sensitivity (mean, 7.33±1.66mg/kg fat-free mass/min).
RESULTS: We observed decreased serum BDNF concentration in women with low insulin sensitivity in comparison to high insulin sensitivity group (3306.11±603.10 vs 4141.91±755.37pg/mL, p=0.001). Serum BDNF was positively related to insulin sensitivity (r=0.43, p=0.003). This correlation remained significant after adjustment for other estimated parameters.
CONCLUSIONS: Serum BDNF is decreased in young nonobese women with low insulin sensitivity. Early detection and prevention of insulin resistance might be useful in the prevention of neurodegenerative disorders.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620811     DOI: 10.1016/j.clinbiochem.2011.05.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

Review 1.  The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): Kill two birds with one stone.

Authors:  Shima Motamedi; Isaac Karimi; Fariba Jafari
Journal:  Metab Brain Dis       Date:  2017-03-30       Impact factor: 3.584

Review 2.  The skinny on brain-derived neurotrophic factor: evidence from animal models to GWAS.

Authors:  Emily G Waterhouse; Baoji Xu
Journal:  J Mol Med (Berl)       Date:  2013-07-05       Impact factor: 4.599

Review 3.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 4.  The Effects of Exercise Training on the Brain-Derived Neurotrophic Factor (BDNF) in the Patients with Type 2 Diabetes: A Systematic Review of the Randomized Controlled Trials.

Authors:  Afsaneh Jamali; Shahnaz Shahrbanian; Seyed Morteza Tayebi
Journal:  J Diabetes Metab Disord       Date:  2020-05-06

5.  Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects.

Authors:  Monika Karczewska-Kupczewska; Irina Kowalska; Agnieszka Nikołajuk; Agnieszka Adamska; Magdalena Zielińska; Natalia Kamińska; Elżbieta Otziomek; Maria Górska; Marek Strączkowski
Journal:  Diabetes Care       Date:  2011-12-30       Impact factor: 19.112

Review 6.  2,4 Dinitrophenol as Medicine.

Authors:  John G Geisler
Journal:  Cells       Date:  2019-03-23       Impact factor: 6.600

7.  The effect of exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2 diabetes.

Authors:  Damon L Swift; Neil M Johannsen; Valerie H Myers; Conrad P Earnest; Jasper A J Smits; Steven N Blair; Timothy S Church
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.

Authors:  I-Te Lee; Chia-Po Fu; Wen-Jane Lee; Kae-Woei Liang; Shih-Yi Lin; Chu-Jen Wan; Wayne Huey-Herng Sheu
Journal:  Diabetol Metab Syndr       Date:  2014-02-13       Impact factor: 3.320

9.  Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu; Yi-Jen Hung; Jung-Fu Chen; Chih-Yuan Wang; Wen-Jane Lee
Journal:  Dis Markers       Date:  2015-03-30       Impact factor: 3.434

10.  The association between serum brain-derived neurotrophic factor and a cluster of cardiovascular risk factors in adolescents: The CHAMPS-study DK.

Authors:  Natascha Holbæk Pedersen; Jakob Tarp; Lars Bo Andersen; Anne Kær Gejl; Tao Huang; Lone Peijs; Anna Bugge
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.